GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
Tag: Receptor
Diabetes medication shows promise in reducing alcohol use
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy
In this interview from SfN 2024, Professor Nancy Ip, President of The Hong Kong University of Science and Technology, shares ...
Novel bladder cancer treatment gains MHRA approval in the UK
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) ...
HMGB1 as a key mediator in liver disease pathogenesis
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates. Acute ...
MD Anderson launches new institute for advancing cell therapy
The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & ...
Anti-inflammatory cytokine linked to capillary obstruction and cognitive decline in diabetes
Researchers discover that capillary obstruction in diabetes, triggered by elevated interleukin-10 signaling, may contribute to cognitive deficits independent of blood ...
Impact of TLR10 rs10004195 genotype on susceptibility to H. pylori infection
Background and objectives Helicobacter pylori (H. pylori) infection can cause multiple secondary digestive disorders. Some studies have found that polymorphisms in ...
Researchers unlock potential of light-controlled cellular activities
Researchers at the Paul Scherrer Institute PSI have succeeded in elucidating the structure of specific photoreceptors. With their help, it ...
Researchers develop strategies to identify regulators of intestinal hormone secretion
A multi-institutional group of researchers led by the Hubrecht Institute and Roche's Institute of Human Biology has developed strategies to ...
